Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?

Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research ...

Zhengye Biotechnology Holding Limited ZYBT shares plunged on Wednesday as traders reassessed the stock after an extreme, ...

Biotechnology investors remain confident in the sector's outlook even after a major comeback this year — and they're picking their positions. The healthcare subsector has quietly become one of the ...

Sana Biotechnology's lead asset still remains to be SC291, repurposed for severe autoimmune disorders instead of blood ...

Vir Biotechnology has partnered with Astellas Pharma to develop VIR-5500, its masked PSMA-targeting T-cell engager for ...

Cellyan Biotechnology Co. Ltd HKPD shares remained under pressure after the company disclosed that it received an additional ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Researchers are increasingly using AI and biotechnology tools to better understand the ...

Explore advancements in biotechnology, from gene editing's ethical dilemmas to synthetic biology's commercial potential and its impact on human life. Read more at straitstimes.com. Read more at ...